"Mast"ering drug discovery with iPSCs.
作者信息
Dorrance Adrienne
机构信息
The Ohio State University.
出版信息
Blood. 2021 Apr 15;137(15):1993-1994. doi: 10.1182/blood.2020010456.
PMID:33856443
Abstract
摘要
相似文献
1
"Mast"ering drug discovery with iPSCs.利用诱导多能干细胞“掌握”药物发现。
Blood. 2021 Apr 15;137(15):1993-1994. doi: 10.1182/blood.2020010456.
2
Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases.利用诱导多能干细胞模型进行神经退行性和眼部疾病的药物发现。
Pharmacol Ther. 2017 Sep;177:32-43. doi: 10.1016/j.pharmthera.2017.02.026. Epub 2017 Feb 14.
3
Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development.诱导多能干细胞及其在人类疾病和发育模型中的应用。
Physiol Rev. 2019 Jan 1;99(1):79-114. doi: 10.1152/physrev.00039.2017.
4
Requirements for Using iPSC-Based Cell Models for Assay Development in Drug Discovery.在药物发现中使用基于诱导多能干细胞（iPSC）的细胞模型进行分析方法开发的要求。
Adv Biochem Eng Biotechnol. 2018;163:207-220. doi: 10.1007/10_2017_23.
5
Induced pluripotent stem cells for neural drug discovery.诱导多能干细胞在神经药物研发中的应用。
Drug Discov Today. 2019 Apr;24(4):992-999. doi: 10.1016/j.drudis.2019.01.007. Epub 2019 Jan 18.
6
iPSC technology: platform for drug discovery. Point.iPSC 技术：药物发现的平台。要点。
Clin Pharmacol Ther. 2011 May;89(5):639-41. doi: 10.1038/clpt.2011.22.
7
A low-cost, high-quality new drug discovery process using patient-derived induced pluripotent stem cells.利用患者来源的诱导多能干细胞的低成本、高质量新药发现流程。
Drug Discov Today. 2015 Jan;20(1):37-49. doi: 10.1016/j.drudis.2014.10.011. Epub 2014 Nov 15.
8
Advances in the Production and Application of Induced Pluripotent Stem Cells.诱导多能干细胞的生产与应用进展
Curr Stem Cell Res Ther. 2017;12(8):637-643. doi: 10.2174/1574888X12666170927115317.
9
How induced pluripotent stem cells are informing drug discovery in psychiatry.诱导多能干细胞如何为精神医学中的药物研发提供信息。
Swiss Med Wkly. 2016 Jan 11;146:w14241. doi: 10.4414/smw.2016.14241. eCollection 2016.
10
Induced Pluripotent Stem Cells (iPSCs) in Developmental Toxicology.发育毒理学中的诱导多能干细胞（iPSC）
Methods Mol Biol. 2019;1965:19-34. doi: 10.1007/978-1-4939-9182-2_3.
引用本文的文献
1
Comprehensive Analysis of Acquired Genetic Variants and Their Prognostic Impact in Systemic Mastocytosis.系统性肥大细胞增多症中获得性基因变异及其预后影响的综合分析
Cancers (Basel). 2022 May 18;14(10):2487. doi: 10.3390/cancers14102487.
2
Precision Medicine in Systemic Mastocytosis.精准医学在系统性肥大细胞增多症中的应用。
Medicina (Kaunas). 2021 Oct 20;57(11):1135. doi: 10.3390/medicina57111135.
Zotero 插件